nodes	percent_of_prediction	percent_of_DWPC	metapath
Agomelatine—CYP1A2—chronic obstructive pulmonary disease	0.562	1	CbGaD
Agomelatine—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.0612	0.27	CbGbCtD
Agomelatine—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.0612	0.27	CbGbCtD
Agomelatine—CYP1A2—Aminophylline—chronic obstructive pulmonary disease	0.0577	0.255	CbGbCtD
Agomelatine—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.0464	0.205	CbGbCtD
Agomelatine—Nabumetone—MPO—chronic obstructive pulmonary disease	0.00196	0.288	CrCbGaD
Agomelatine—Depression—Roflumilast—chronic obstructive pulmonary disease	0.0016	0.0108	CcSEcCtD
Agomelatine—Aggression—Salbutamol—chronic obstructive pulmonary disease	0.00156	0.0105	CcSEcCtD
Agomelatine—Hepatobiliary disease—Roflumilast—chronic obstructive pulmonary disease	0.00152	0.0102	CcSEcCtD
Agomelatine—Connective tissue disorder—Roflumilast—chronic obstructive pulmonary disease	0.00142	0.00951	CcSEcCtD
Agomelatine—Nightmare—Salbutamol—chronic obstructive pulmonary disease	0.00133	0.00892	CcSEcCtD
Agomelatine—Irritability—Aminophylline—chronic obstructive pulmonary disease	0.00133	0.00891	CcSEcCtD
Agomelatine—Mental disorder—Roflumilast—chronic obstructive pulmonary disease	0.00126	0.00848	CcSEcCtD
Agomelatine—Back pain—Roflumilast—chronic obstructive pulmonary disease	0.00121	0.00815	CcSEcCtD
Agomelatine—Tremor—Roflumilast—chronic obstructive pulmonary disease	0.00118	0.0079	CcSEcCtD
Agomelatine—Eczema—Montelukast—chronic obstructive pulmonary disease	0.00115	0.00774	CcSEcCtD
Agomelatine—Angioedema—Roflumilast—chronic obstructive pulmonary disease	0.00115	0.0077	CcSEcCtD
Agomelatine—Nabumetone—CYP1A2—chronic obstructive pulmonary disease	0.00113	0.167	CrCbGaD
Agomelatine—Vertigo—Roflumilast—chronic obstructive pulmonary disease	0.00113	0.00757	CcSEcCtD
Agomelatine—Eczema—Salbutamol—chronic obstructive pulmonary disease	0.00111	0.00746	CcSEcCtD
Agomelatine—Anxiety—Roflumilast—chronic obstructive pulmonary disease	0.00106	0.00715	CcSEcCtD
Agomelatine—Unspecified disorder of skin and subcutaneous tissue—Roflumilast—chronic obstructive pulmonary disease	0.00106	0.00713	CcSEcCtD
Agomelatine—Infection—Roflumilast—chronic obstructive pulmonary disease	0.00102	0.00683	CcSEcCtD
Agomelatine—Nervous system disorder—Roflumilast—chronic obstructive pulmonary disease	0.001	0.00675	CcSEcCtD
Agomelatine—Skin disorder—Roflumilast—chronic obstructive pulmonary disease	0.000994	0.00668	CcSEcCtD
Agomelatine—Irritability—Montelukast—chronic obstructive pulmonary disease	0.000988	0.00664	CcSEcCtD
Agomelatine—Migraine—Salbutamol—chronic obstructive pulmonary disease	0.000982	0.0066	CcSEcCtD
Agomelatine—Irritability—Salbutamol—chronic obstructive pulmonary disease	0.000953	0.0064	CcSEcCtD
Agomelatine—Nasopharyngitis—Formoterol—chronic obstructive pulmonary disease	0.000945	0.00635	CcSEcCtD
Agomelatine—Nasopharyngitis—Arformoterol—chronic obstructive pulmonary disease	0.000945	0.00635	CcSEcCtD
Agomelatine—Indomethacin—CXCL8—chronic obstructive pulmonary disease	0.000944	0.139	CrCbGaD
Agomelatine—Nasopharyngitis—Montelukast—chronic obstructive pulmonary disease	0.000926	0.00622	CcSEcCtD
Agomelatine—Insomnia—Roflumilast—chronic obstructive pulmonary disease	0.000926	0.00622	CcSEcCtD
Agomelatine—Influenza—Arformoterol—chronic obstructive pulmonary disease	0.000914	0.00614	CcSEcCtD
Agomelatine—Influenza—Formoterol—chronic obstructive pulmonary disease	0.000914	0.00614	CcSEcCtD
Agomelatine—Dyspepsia—Roflumilast—chronic obstructive pulmonary disease	0.000901	0.00605	CcSEcCtD
Agomelatine—Influenza—Montelukast—chronic obstructive pulmonary disease	0.000895	0.00601	CcSEcCtD
Agomelatine—Nasopharyngitis—Salbutamol—chronic obstructive pulmonary disease	0.000893	0.006	CcSEcCtD
Agomelatine—Connective tissue disorder—Tiotropium—chronic obstructive pulmonary disease	0.00089	0.00598	CcSEcCtD
Agomelatine—Gastrointestinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.000884	0.00594	CcSEcCtD
Agomelatine—Fatigue—Roflumilast—chronic obstructive pulmonary disease	0.000883	0.00593	CcSEcCtD
Agomelatine—Constipation—Roflumilast—chronic obstructive pulmonary disease	0.000875	0.00588	CcSEcCtD
Agomelatine—Influenza—Salbutamol—chronic obstructive pulmonary disease	0.000863	0.0058	CcSEcCtD
Agomelatine—Eye disorder—Tiotropium—chronic obstructive pulmonary disease	0.000847	0.00569	CcSEcCtD
Agomelatine—Gastrointestinal pain—Roflumilast—chronic obstructive pulmonary disease	0.000837	0.00562	CcSEcCtD
Agomelatine—Suicidal ideation—Prednisone—chronic obstructive pulmonary disease	0.000817	0.00549	CcSEcCtD
Agomelatine—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.000813	0.00546	CcSEcCtD
Agomelatine—Abdominal pain—Roflumilast—chronic obstructive pulmonary disease	0.000809	0.00544	CcSEcCtD
Agomelatine—Infestation NOS—Montelukast—chronic obstructive pulmonary disease	0.000798	0.00536	CcSEcCtD
Agomelatine—Infestation—Montelukast—chronic obstructive pulmonary disease	0.000798	0.00536	CcSEcCtD
Agomelatine—Mental disorder—Tiotropium—chronic obstructive pulmonary disease	0.000794	0.00533	CcSEcCtD
Agomelatine—Mania—Prednisone—chronic obstructive pulmonary disease	0.000788	0.0053	CcSEcCtD
Agomelatine—Tremor—Aminophylline—chronic obstructive pulmonary disease	0.000784	0.00527	CcSEcCtD
Agomelatine—Melatonin—MPO—chronic obstructive pulmonary disease	0.00078	0.115	CrCbGaD
Agomelatine—Jaundice—Montelukast—chronic obstructive pulmonary disease	0.000778	0.00523	CcSEcCtD
Agomelatine—Agitation—Aminophylline—chronic obstructive pulmonary disease	0.000769	0.00517	CcSEcCtD
Agomelatine—Back pain—Tiotropium—chronic obstructive pulmonary disease	0.000763	0.00513	CcSEcCtD
Agomelatine—Hepatobiliary disease—Montelukast—chronic obstructive pulmonary disease	0.000755	0.00507	CcSEcCtD
Agomelatine—Jaundice—Salbutamol—chronic obstructive pulmonary disease	0.00075	0.00504	CcSEcCtD
Agomelatine—Vision blurred—Tiotropium—chronic obstructive pulmonary disease	0.000743	0.005	CcSEcCtD
Agomelatine—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.000734	0.00494	CcSEcCtD
Agomelatine—Angioedema—Tiotropium—chronic obstructive pulmonary disease	0.000721	0.00484	CcSEcCtD
Agomelatine—Connective tissue disorder—Arformoterol—chronic obstructive pulmonary disease	0.000719	0.00483	CcSEcCtD
Agomelatine—Connective tissue disorder—Formoterol—chronic obstructive pulmonary disease	0.000719	0.00483	CcSEcCtD
Agomelatine—Hepatitis—Montelukast—chronic obstructive pulmonary disease	0.000716	0.00481	CcSEcCtD
Agomelatine—Hallucination—Montelukast—chronic obstructive pulmonary disease	0.000713	0.00479	CcSEcCtD
Agomelatine—Anxiety—Aminophylline—chronic obstructive pulmonary disease	0.00071	0.00477	CcSEcCtD
Agomelatine—Connective tissue disorder—Montelukast—chronic obstructive pulmonary disease	0.000704	0.00473	CcSEcCtD
Agomelatine—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.0007	0.00471	CcSEcCtD
Agomelatine—Connective tissue disorder—Salbutamol—chronic obstructive pulmonary disease	0.000679	0.00456	CcSEcCtD
Agomelatine—Infection—Aminophylline—chronic obstructive pulmonary disease	0.000678	0.00456	CcSEcCtD
Agomelatine—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.000677	0.00455	CcSEcCtD
Agomelatine—Nervous system disorder—Aminophylline—chronic obstructive pulmonary disease	0.000669	0.0045	CcSEcCtD
Agomelatine—Unspecified disorder of skin and subcutaneous tissue—Tiotropium—chronic obstructive pulmonary disease	0.000667	0.00448	CcSEcCtD
Agomelatine—Dry mouth—Tiotropium—chronic obstructive pulmonary disease	0.000657	0.00441	CcSEcCtD
Agomelatine—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.000651	0.00437	CcSEcCtD
Agomelatine—Tinnitus—Salbutamol—chronic obstructive pulmonary disease	0.000644	0.00433	CcSEcCtD
Agomelatine—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000641	0.00431	CcSEcCtD
Agomelatine—Mental disorder—Formoterol—chronic obstructive pulmonary disease	0.000641	0.00431	CcSEcCtD
Agomelatine—Mental disorder—Arformoterol—chronic obstructive pulmonary disease	0.000641	0.00431	CcSEcCtD
Agomelatine—Infection—Tiotropium—chronic obstructive pulmonary disease	0.00064	0.0043	CcSEcCtD
Agomelatine—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	0.000631	0.00424	CcSEcCtD
Agomelatine—Mental disorder—Montelukast—chronic obstructive pulmonary disease	0.000628	0.00422	CcSEcCtD
Agomelatine—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.000625	0.0042	CcSEcCtD
Agomelatine—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.000617	0.00415	CcSEcCtD
Agomelatine—Back pain—Arformoterol—chronic obstructive pulmonary disease	0.000616	0.00414	CcSEcCtD
Agomelatine—Back pain—Formoterol—chronic obstructive pulmonary disease	0.000616	0.00414	CcSEcCtD
Agomelatine—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000608	0.00409	CcSEcCtD
Agomelatine—Mental disorder—Salbutamol—chronic obstructive pulmonary disease	0.000605	0.00406	CcSEcCtD
Agomelatine—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.000601	0.00404	CcSEcCtD
Agomelatine—Tremor—Formoterol—chronic obstructive pulmonary disease	0.000596	0.00401	CcSEcCtD
Agomelatine—Tremor—Arformoterol—chronic obstructive pulmonary disease	0.000596	0.00401	CcSEcCtD
Agomelatine—Agitation—Formoterol—chronic obstructive pulmonary disease	0.000585	0.00393	CcSEcCtD
Agomelatine—Agitation—Arformoterol—chronic obstructive pulmonary disease	0.000585	0.00393	CcSEcCtD
Agomelatine—Tremor—Montelukast—chronic obstructive pulmonary disease	0.000584	0.00393	CcSEcCtD
Agomelatine—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.000582	0.00391	CcSEcCtD
Agomelatine—Angioedema—Arformoterol—chronic obstructive pulmonary disease	0.000582	0.00391	CcSEcCtD
Agomelatine—Angioedema—Formoterol—chronic obstructive pulmonary disease	0.000582	0.00391	CcSEcCtD
Agomelatine—Back pain—Salbutamol—chronic obstructive pulmonary disease	0.000581	0.00391	CcSEcCtD
Agomelatine—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.000578	0.00388	CcSEcCtD
Agomelatine—Agitation—Montelukast—chronic obstructive pulmonary disease	0.000573	0.00385	CcSEcCtD
Agomelatine—Angioedema—Montelukast—chronic obstructive pulmonary disease	0.00057	0.00383	CcSEcCtD
Agomelatine—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.000567	0.00381	CcSEcCtD
Agomelatine—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.000563	0.00378	CcSEcCtD
Agomelatine—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000558	0.00375	CcSEcCtD
Agomelatine—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000556	0.00373	CcSEcCtD
Agomelatine—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.000552	0.00371	CcSEcCtD
Agomelatine—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.000551	0.0037	CcSEcCtD
Agomelatine—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.000549	0.00369	CcSEcCtD
Agomelatine—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000542	0.00364	CcSEcCtD
Agomelatine—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.00054	0.00363	CcSEcCtD
Agomelatine—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.00054	0.00363	CcSEcCtD
Agomelatine—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.00054	0.00363	CcSEcCtD
Agomelatine—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.00054	0.00363	CcSEcCtD
Agomelatine—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000538	0.00362	CcSEcCtD
Agomelatine—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000538	0.00362	CcSEcCtD
Agomelatine—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.00053	0.00356	CcSEcCtD
Agomelatine—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.00053	0.00356	CcSEcCtD
Agomelatine—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000529	0.00355	CcSEcCtD
Agomelatine—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000527	0.00354	CcSEcCtD
Agomelatine—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000526	0.00354	CcSEcCtD
Agomelatine—Naproxen—CYP1A2—chronic obstructive pulmonary disease	0.000524	0.077	CrCbGaD
Agomelatine—Infection—Formoterol—chronic obstructive pulmonary disease	0.000516	0.00347	CcSEcCtD
Agomelatine—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000516	0.00347	CcSEcCtD
Agomelatine—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000511	0.00344	CcSEcCtD
Agomelatine—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.00051	0.00343	CcSEcCtD
Agomelatine—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.00051	0.00342	CcSEcCtD
Agomelatine—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.00051	0.00342	CcSEcCtD
Agomelatine—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000509	0.00342	CcSEcCtD
Agomelatine—Infection—Montelukast—chronic obstructive pulmonary disease	0.000506	0.0034	CcSEcCtD
Agomelatine—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000505	0.00339	CcSEcCtD
Agomelatine—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000505	0.00339	CcSEcCtD
Agomelatine—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.0005	0.00336	CcSEcCtD
Agomelatine—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000499	0.00335	CcSEcCtD
Agomelatine—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000494	0.00332	CcSEcCtD
Agomelatine—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000487	0.00327	CcSEcCtD
Agomelatine—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000483	0.00325	CcSEcCtD
Agomelatine—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000481	0.00323	CcSEcCtD
Agomelatine—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000477	0.0032	CcSEcCtD
Agomelatine—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000474	0.00319	CcSEcCtD
Agomelatine—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.00047	0.00316	CcSEcCtD
Agomelatine—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.00047	0.00316	CcSEcCtD
Agomelatine—Melatonin—CYP1A1—chronic obstructive pulmonary disease	0.000468	0.0688	CrCbGaD
Agomelatine—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000467	0.00314	CcSEcCtD
Agomelatine—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000462	0.0031	CcSEcCtD
Agomelatine—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000462	0.0031	CcSEcCtD
Agomelatine—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.00046	0.00309	CcSEcCtD
Agomelatine—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000457	0.00307	CcSEcCtD
Agomelatine—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000457	0.00307	CcSEcCtD
Agomelatine—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000457	0.00307	CcSEcCtD
Agomelatine—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000455	0.00306	CcSEcCtD
Agomelatine—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000452	0.00304	CcSEcCtD
Agomelatine—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000451	0.00303	CcSEcCtD
Agomelatine—Melatonin—CYP1A2—chronic obstructive pulmonary disease	0.000451	0.0663	CrCbGaD
Agomelatine—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.00045	0.00303	CcSEcCtD
Agomelatine—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000449	0.00301	CcSEcCtD
Agomelatine—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000449	0.00301	CcSEcCtD
Agomelatine—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000448	0.00301	CcSEcCtD
Agomelatine—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000448	0.00301	CcSEcCtD
Agomelatine—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000448	0.00301	CcSEcCtD
Agomelatine—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000444	0.00299	CcSEcCtD
Agomelatine—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000444	0.00299	CcSEcCtD
Agomelatine—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000444	0.00298	CcSEcCtD
Agomelatine—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000441	0.00296	CcSEcCtD
Agomelatine—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000439	0.00295	CcSEcCtD
Agomelatine—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000439	0.00295	CcSEcCtD
Agomelatine—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000436	0.00293	CcSEcCtD
Agomelatine—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000434	0.00292	CcSEcCtD
Agomelatine—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000432	0.0029	CcSEcCtD
Agomelatine—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000428	0.00287	CcSEcCtD
Agomelatine—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000426	0.00286	CcSEcCtD
Agomelatine—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000425	0.00285	CcSEcCtD
Agomelatine—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000425	0.00285	CcSEcCtD
Agomelatine—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000424	0.00285	CcSEcCtD
Agomelatine—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000423	0.00284	CcSEcCtD
Agomelatine—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.00042	0.00282	CcSEcCtD
Agomelatine—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000416	0.0028	CcSEcCtD
Agomelatine—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000413	0.00277	CcSEcCtD
Agomelatine—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000413	0.00277	CcSEcCtD
Agomelatine—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000411	0.00276	CcSEcCtD
Agomelatine—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000411	0.00276	CcSEcCtD
Agomelatine—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000409	0.00275	CcSEcCtD
Agomelatine—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000405	0.00272	CcSEcCtD
Agomelatine—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000404	0.00272	CcSEcCtD
Agomelatine—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000403	0.00271	CcSEcCtD
Agomelatine—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000402	0.0027	CcSEcCtD
Agomelatine—Face oedema—Prednisone—chronic obstructive pulmonary disease	0.000402	0.0027	CcSEcCtD
Agomelatine—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000401	0.0027	CcSEcCtD
Agomelatine—Irritability—Prednisone—chronic obstructive pulmonary disease	0.000397	0.00267	CcSEcCtD
Agomelatine—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.00039	0.00262	CcSEcCtD
Agomelatine—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000388	0.00261	CcSEcCtD
Agomelatine—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000382	0.00257	CcSEcCtD
Agomelatine—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000373	0.0025	CcSEcCtD
Agomelatine—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000373	0.0025	CcSEcCtD
Agomelatine—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000368	0.00247	CcSEcCtD
Agomelatine—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000368	0.00247	CcSEcCtD
Agomelatine—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000365	0.00245	CcSEcCtD
Agomelatine—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.00036	0.00242	CcSEcCtD
Agomelatine—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000355	0.00239	CcSEcCtD
Agomelatine—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000355	0.00239	CcSEcCtD
Agomelatine—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000352	0.00237	CcSEcCtD
Agomelatine—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000348	0.00234	CcSEcCtD
Agomelatine—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000347	0.00233	CcSEcCtD
Agomelatine—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000344	0.00231	CcSEcCtD
Agomelatine—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000344	0.00231	CcSEcCtD
Agomelatine—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000337	0.00226	CcSEcCtD
Agomelatine—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000336	0.00226	CcSEcCtD
Agomelatine—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.00033	0.00222	CcSEcCtD
Agomelatine—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.00033	0.00222	CcSEcCtD
Agomelatine—Weight increased—Prednisone—chronic obstructive pulmonary disease	0.000327	0.0022	CcSEcCtD
Agomelatine—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000325	0.00219	CcSEcCtD
Agomelatine—Headache—Formoterol—chronic obstructive pulmonary disease	0.000325	0.00219	CcSEcCtD
Agomelatine—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.000325	0.00219	CcSEcCtD
Agomelatine—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000325	0.00218	CcSEcCtD
Agomelatine—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000324	0.00218	CcSEcCtD
Agomelatine—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000324	0.00217	CcSEcCtD
Agomelatine—Depression—Prednisone—chronic obstructive pulmonary disease	0.00032	0.00215	CcSEcCtD
Agomelatine—Headache—Montelukast—chronic obstructive pulmonary disease	0.000319	0.00214	CcSEcCtD
Agomelatine—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000315	0.00212	CcSEcCtD
Agomelatine—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000312	0.0021	CcSEcCtD
Agomelatine—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.00031	0.00208	CcSEcCtD
Agomelatine—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000309	0.00207	CcSEcCtD
Agomelatine—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000309	0.00207	CcSEcCtD
Agomelatine—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000307	0.00207	CcSEcCtD
Agomelatine—Naproxen—ALB—chronic obstructive pulmonary disease	0.000303	0.0445	CrCbGaD
Agomelatine—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000302	0.00203	CcSEcCtD
Agomelatine—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000291	0.00196	CcSEcCtD
Agomelatine—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.000286	0.00192	CcSEcCtD
Agomelatine—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000283	0.0019	CcSEcCtD
Agomelatine—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000272	0.00183	CcSEcCtD
Agomelatine—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000269	0.00181	CcSEcCtD
Agomelatine—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000254	0.00171	CcSEcCtD
Agomelatine—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000253	0.0017	CcSEcCtD
Agomelatine—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000252	0.00169	CcSEcCtD
Agomelatine—Indomethacin—ALB—chronic obstructive pulmonary disease	0.000245	0.036	CrCbGaD
Agomelatine—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000236	0.00159	CcSEcCtD
Agomelatine—Agitation—Prednisone—chronic obstructive pulmonary disease	0.00023	0.00155	CcSEcCtD
Agomelatine—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.000229	0.00154	CcSEcCtD
Agomelatine—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000225	0.00151	CcSEcCtD
Agomelatine—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000224	0.0015	CcSEcCtD
Agomelatine—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000213	0.00143	CcSEcCtD
Agomelatine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000212	0.00142	CcSEcCtD
Agomelatine—CYP2C9—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000203	0.00364	CbGpPWpGaD
Agomelatine—Infection—Prednisone—chronic obstructive pulmonary disease	0.000203	0.00136	CcSEcCtD
Agomelatine—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000201	0.00135	CcSEcCtD
Agomelatine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000199	0.00356	CbGpPWpGaD
Agomelatine—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000199	0.00133	CcSEcCtD
Agomelatine—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000198	0.00133	CcSEcCtD
Agomelatine—CYP2C9—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000196	0.00351	CbGpPWpGaD
Agomelatine—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000186	0.00125	CcSEcCtD
Agomelatine—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000185	0.00124	CcSEcCtD
Agomelatine—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000184	0.00123	CcSEcCtD
Agomelatine—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.00018	0.00121	CcSEcCtD
Agomelatine—HTR2B—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	0.000178	0.00319	CbGpPWpGaD
Agomelatine—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000176	0.00118	CcSEcCtD
Agomelatine—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000176	0.00118	CcSEcCtD
Agomelatine—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000175	0.00117	CcSEcCtD
Agomelatine—CYP1A2—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000174	0.00311	CbGpPWpGaD
Agomelatine—HTR2C—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	0.000168	0.00301	CbGpPWpGaD
Agomelatine—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000167	0.00112	CcSEcCtD
Agomelatine—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000167	0.00112	CcSEcCtD
Agomelatine—MTNR1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	0.000167	0.003	CbGpPWpGaD
Agomelatine—MTNR1B—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	0.000167	0.003	CbGpPWpGaD
Agomelatine—CYP2C9—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000167	0.00299	CbGpPWpGaD
Agomelatine—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000162	0.00109	CcSEcCtD
Agomelatine—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000162	0.00109	CcSEcCtD
Agomelatine—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000161	0.00289	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.000158	0.00283	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.000158	0.00283	CbGpPWpGaD
Agomelatine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—chronic obstructive pulmonary disease	0.000153	0.00273	CbGpPWpGaD
Agomelatine—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—chronic obstructive pulmonary disease	0.000153	0.00273	CbGpPWpGaD
Agomelatine—CYP1A2—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000153	0.00273	CbGpPWpGaD
Agomelatine—HTR2B—G alpha (q) signalling events—EDN1—chronic obstructive pulmonary disease	0.000151	0.0027	CbGpPWpGaD
Agomelatine—CYP1A2—Phase II conjugation—GSTT1—chronic obstructive pulmonary disease	0.00015	0.0027	CbGpPWpGaD
Agomelatine—MTNR1A—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	0.000149	0.00267	CbGpPWpGaD
Agomelatine—MTNR1B—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	0.000149	0.00267	CbGpPWpGaD
Agomelatine—CYP1A2—Phase II conjugation—GCLC—chronic obstructive pulmonary disease	0.000149	0.00266	CbGpPWpGaD
Agomelatine—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000147	0.000986	CcSEcCtD
Agomelatine—MTNR1B—Circadian rythm related genes—TP53—chronic obstructive pulmonary disease	0.000146	0.00262	CbGpPWpGaD
Agomelatine—MTNR1A—Circadian rythm related genes—TP53—chronic obstructive pulmonary disease	0.000146	0.00262	CbGpPWpGaD
Agomelatine—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000145	0.000972	CcSEcCtD
Agomelatine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000144	0.00259	CbGpPWpGaD
Agomelatine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	0.000144	0.00257	CbGpPWpGaD
Agomelatine—CYP1A2—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000143	0.00256	CbGpPWpGaD
Agomelatine—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000142	0.00255	CbGpPWpGaD
Agomelatine—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.00014	0.00094	CcSEcCtD
Agomelatine—HTR2B—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	0.000136	0.00243	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	0.000135	0.00242	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	0.000135	0.00242	CbGpPWpGaD
Agomelatine—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000135	0.000909	CcSEcCtD
Agomelatine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—chronic obstructive pulmonary disease	0.000135	0.00242	CbGpPWpGaD
Agomelatine—MTNR1A—Circadian rythm related genes—IL6—chronic obstructive pulmonary disease	0.000134	0.0024	CbGpPWpGaD
Agomelatine—MTNR1B—Circadian rythm related genes—IL6—chronic obstructive pulmonary disease	0.000134	0.0024	CbGpPWpGaD
Agomelatine—MTNR1A—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	0.000133	0.00238	CbGpPWpGaD
Agomelatine—MTNR1B—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	0.000133	0.00238	CbGpPWpGaD
Agomelatine—HTR2B—G alpha (q) signalling events—HTR2A—chronic obstructive pulmonary disease	0.000132	0.00236	CbGpPWpGaD
Agomelatine—HTR2B—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	0.00013	0.00234	CbGpPWpGaD
Agomelatine—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.00013	0.000874	CcSEcCtD
Agomelatine—Headache—Prednisone—chronic obstructive pulmonary disease	0.000128	0.000861	CcSEcCtD
Agomelatine—MTNR1B—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	0.000127	0.00228	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	0.000127	0.00228	CbGpPWpGaD
Agomelatine—MTNR1A—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	0.000127	0.00228	CbGpPWpGaD
Agomelatine—MTNR1B—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	0.000127	0.00228	CbGpPWpGaD
Agomelatine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000123	0.00221	CbGpPWpGaD
Agomelatine—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000122	0.00218	CbGpPWpGaD
Agomelatine—HTR2C—G alpha (q) signalling events—EDN1—chronic obstructive pulmonary disease	0.000122	0.00218	CbGpPWpGaD
Agomelatine—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000121	0.000816	CcSEcCtD
Agomelatine—MTNR1B—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	0.000121	0.00217	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	0.000121	0.00217	CbGpPWpGaD
Agomelatine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—chronic obstructive pulmonary disease	0.000118	0.00211	CbGpPWpGaD
Agomelatine—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000117	0.0021	CbGpPWpGaD
Agomelatine—MTNR1B—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	0.000116	0.00209	CbGpPWpGaD
Agomelatine—MTNR1A—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	0.000116	0.00209	CbGpPWpGaD
Agomelatine—HTR2B—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	0.000112	0.002	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.000111	0.00199	CbGpPWpGaD
Agomelatine—HTR2C—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	0.000109	0.00196	CbGpPWpGaD
Agomelatine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—chronic obstructive pulmonary disease	0.000109	0.00195	CbGpPWpGaD
Agomelatine—HTR2C—G alpha (q) signalling events—HTR2A—chronic obstructive pulmonary disease	0.000106	0.00191	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	0.000106	0.00189	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	0.000106	0.00189	CbGpPWpGaD
Agomelatine—HTR2C—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	0.000105	0.00189	CbGpPWpGaD
Agomelatine—CYP1A2—Phase II conjugation—GSTP1—chronic obstructive pulmonary disease	0.000104	0.00187	CbGpPWpGaD
Agomelatine—CYP2C9—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000103	0.00185	CbGpPWpGaD
Agomelatine—HTR2B—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	0.000102	0.00183	CbGpPWpGaD
Agomelatine—CYP2C9—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000102	0.00182	CbGpPWpGaD
Agomelatine—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.0001	0.00179	CbGpPWpGaD
Agomelatine—HTR2B—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	9.98e-05	0.00179	CbGpPWpGaD
Agomelatine—CYP1A2—Phase II conjugation—GSTM1—chronic obstructive pulmonary disease	9.58e-05	0.00172	CbGpPWpGaD
Agomelatine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—chronic obstructive pulmonary disease	9.51e-05	0.00171	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	9.51e-05	0.0017	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	9.31e-05	0.00167	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	9.31e-05	0.00167	CbGpPWpGaD
Agomelatine—HTR2C—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	9.01e-05	0.00162	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	8.96e-05	0.00161	CbGpPWpGaD
Agomelatine—CYP1A2—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	8.8e-05	0.00158	CbGpPWpGaD
Agomelatine—HTR2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	8.73e-05	0.00157	CbGpPWpGaD
Agomelatine—CYP1A2—Biological oxidations—GCLC—chronic obstructive pulmonary disease	8.7e-05	0.00156	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—KL—chronic obstructive pulmonary disease	8.65e-05	0.00155	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—KL—chronic obstructive pulmonary disease	8.65e-05	0.00155	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	8.63e-05	0.00155	CbGpPWpGaD
Agomelatine—CYP2C9—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	8.56e-05	0.00153	CbGpPWpGaD
Agomelatine—HTR2B—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	8.51e-05	0.00152	CbGpPWpGaD
Agomelatine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—chronic obstructive pulmonary disease	8.44e-05	0.00151	CbGpPWpGaD
Agomelatine—CYP2C9—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	8.44e-05	0.00151	CbGpPWpGaD
Agomelatine—HTR2C—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	8.22e-05	0.00147	CbGpPWpGaD
Agomelatine—HTR2C—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	8.05e-05	0.00144	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	7.99e-05	0.00143	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	7.99e-05	0.00143	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	7.67e-05	0.00137	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	7.66e-05	0.00137	CbGpPWpGaD
Agomelatine—HTR2B—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	7.6e-05	0.00136	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	7.24e-05	0.0013	CbGpPWpGaD
Agomelatine—MTNR1B—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	7.19e-05	0.00129	CbGpPWpGaD
Agomelatine—MTNR1A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	7.19e-05	0.00129	CbGpPWpGaD
Agomelatine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	7.15e-05	0.00128	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	7.14e-05	0.00128	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	7.14e-05	0.00128	CbGpPWpGaD
Agomelatine—CYP2C9—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	7.14e-05	0.00128	CbGpPWpGaD
Agomelatine—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	7.04e-05	0.00126	CbGpPWpGaD
Agomelatine—CYP2C9—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	7.04e-05	0.00126	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	6.96e-05	0.00125	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	6.96e-05	0.00125	CbGpPWpGaD
Agomelatine—HTR2C—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	6.86e-05	0.00123	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	6.73e-05	0.00121	CbGpPWpGaD
Agomelatine—HTR2B—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	6.65e-05	0.00119	CbGpPWpGaD
Agomelatine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic obstructive pulmonary disease	6.56e-05	0.00118	CbGpPWpGaD
Agomelatine—CYP2C9—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	6.56e-05	0.00118	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	6.53e-05	0.00117	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	6.53e-05	0.00117	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	6.49e-05	0.00116	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	6.49e-05	0.00116	CbGpPWpGaD
Agomelatine—CYP2C9—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	6.47e-05	0.00116	CbGpPWpGaD
Agomelatine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—chronic obstructive pulmonary disease	6.43e-05	0.00115	CbGpPWpGaD
Agomelatine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	6.43e-05	0.00115	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	6.24e-05	0.00112	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	6.24e-05	0.00112	CbGpPWpGaD
Agomelatine—CYP2C9—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	6.22e-05	0.00111	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	6.18e-05	0.00111	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	6.18e-05	0.00111	CbGpPWpGaD
Agomelatine—HTR2C—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	6.13e-05	0.0011	CbGpPWpGaD
Agomelatine—CYP2C9—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	6.13e-05	0.0011	CbGpPWpGaD
Agomelatine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	6.13e-05	0.0011	CbGpPWpGaD
Agomelatine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	6.13e-05	0.0011	CbGpPWpGaD
Agomelatine—CYP1A2—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	6.1e-05	0.00109	CbGpPWpGaD
Agomelatine—CYP1A2—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	6.01e-05	0.00108	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	5.8e-05	0.00104	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—LEP—chronic obstructive pulmonary disease	5.8e-05	0.00104	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	5.61e-05	0.00101	CbGpPWpGaD
Agomelatine—CYP1A2—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	5.6e-05	0.001	CbGpPWpGaD
Agomelatine—CYP1A2—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	5.53e-05	0.000991	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	5.43e-05	0.000973	CbGpPWpGaD
Agomelatine—HTR2B—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	5.39e-05	0.000967	CbGpPWpGaD
Agomelatine—HTR2C—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	5.36e-05	0.000961	CbGpPWpGaD
Agomelatine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	5.32e-05	0.000954	CbGpPWpGaD
Agomelatine—CYP1A2—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	5.31e-05	0.000952	CbGpPWpGaD
Agomelatine—CYP1A2—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	5.24e-05	0.000939	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	5.1e-05	0.000914	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—APIP—chronic obstructive pulmonary disease	5e-05	0.000896	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	4.81e-05	0.000862	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	4.77e-05	0.000855	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	4.77e-05	0.000855	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	4.56e-05	0.000816	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	4.56e-05	0.000816	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	4.36e-05	0.000782	CbGpPWpGaD
Agomelatine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	4.35e-05	0.00078	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.35e-05	0.000779	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.35e-05	0.000779	CbGpPWpGaD
Agomelatine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	4.3e-05	0.00077	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	4.3e-05	0.00077	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—APIP—chronic obstructive pulmonary disease	4.27e-05	0.000766	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	4.11e-05	0.000737	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	4.11e-05	0.000737	CbGpPWpGaD
Agomelatine—HTR2B—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	4.11e-05	0.000736	CbGpPWpGaD
Agomelatine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	4.09e-05	0.000733	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	3.9e-05	0.000699	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	3.88e-05	0.000695	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.86e-05	0.000691	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.86e-05	0.000691	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	3.76e-05	0.000673	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.67e-05	0.000657	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.67e-05	0.000657	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	3.57e-05	0.000639	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	3.52e-05	0.000631	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.49e-05	0.000625	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.49e-05	0.000625	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	3.47e-05	0.000621	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	3.41e-05	0.000612	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	3.32e-05	0.000594	CbGpPWpGaD
Agomelatine—HTR2C—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	3.31e-05	0.000594	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.31e-05	0.000594	CbGpPWpGaD
Agomelatine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	3.3e-05	0.000592	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	3.29e-05	0.000589	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	3.22e-05	0.000578	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	3.15e-05	0.000564	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.13e-05	0.000562	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.13e-05	0.000562	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	3.05e-05	0.000546	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	3.03e-05	0.000543	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	3.01e-05	0.000539	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3e-05	0.000537	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.88e-05	0.000515	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.88e-05	0.000515	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.83e-05	0.000507	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.82e-05	0.000505	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.82e-05	0.000505	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—KL—chronic obstructive pulmonary disease	2.79e-05	0.000501	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—GC—chronic obstructive pulmonary disease	2.75e-05	0.000494	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	2.75e-05	0.000493	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	2.58e-05	0.000462	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.56e-05	0.000459	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	2.42e-05	0.000435	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.39e-05	0.000428	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.37e-05	0.000424	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.37e-05	0.000424	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	2.32e-05	0.000416	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	2.3e-05	0.000413	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—KL—chronic obstructive pulmonary disease	2.25e-05	0.000404	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.17e-05	0.000388	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.17e-05	0.000388	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	2.11e-05	0.000378	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	2.09e-05	0.000375	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	2.08e-05	0.000373	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.04e-05	0.000366	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	2.02e-05	0.000361	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.87e-05	0.000336	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.87e-05	0.000336	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.86e-05	0.000333	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.76e-05	0.000316	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	1.74e-05	0.000312	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.7e-05	0.000305	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.69e-05	0.000303	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.63e-05	0.000291	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.62e-05	0.000291	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	1.59e-05	0.000285	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.54e-05	0.000276	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.51e-05	0.000271	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.5e-05	0.00027	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	1.49e-05	0.000267	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.47e-05	0.000264	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.46e-05	0.000262	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.4e-05	0.000252	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.39e-05	0.000249	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	1.36e-05	0.000243	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.25e-05	0.000223	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.24e-05	0.000223	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.22e-05	0.000219	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.2e-05	0.000216	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.19e-05	0.000213	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.18e-05	0.000212	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.13e-05	0.000203	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.13e-05	0.000202	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.12e-05	0.000201	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.06e-05	0.000191	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.04e-05	0.000187	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.03e-05	0.000184	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.01e-05	0.000181	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1e-05	0.00018	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.58e-06	0.000172	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	9.55e-06	0.000171	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	9.28e-06	0.000166	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	9.1e-06	0.000163	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	9.09e-06	0.000163	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	9.09e-06	0.000163	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	8.16e-06	0.000146	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—TP53—chronic obstructive pulmonary disease	7.64e-06	0.000137	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	7.49e-06	0.000134	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	7.34e-06	0.000132	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	7.23e-06	0.00013	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—IL6—chronic obstructive pulmonary disease	7e-06	0.000125	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	6.91e-06	0.000124	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	6.18e-06	0.000111	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—TP53—chronic obstructive pulmonary disease	6.17e-06	0.000111	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	5.91e-06	0.000106	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—IL6—chronic obstructive pulmonary disease	5.64e-06	0.000101	CbGpPWpGaD
